US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist

2.0500
-0.3100-13.14%

Close Nov 15 16:00 ET

2.0700
+0.0200+0.98%

Post 19:14 ET

137.74MMarket Cap-657P/E (TTM)

Inhibikase Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-10.71%-5.05M

35.25%-3.87M

-4.23%-18.09M

3.20%-3.44M

25.43%-4.11M

-4.81%-4.57M

-51.80%-5.97M

-21.36%-17.35M

13.17%-3.56M

-172.44%-5.5M

Net income from continuing operations

14.16%-4.96M

-3.84%-4.65M

-5.40%-19.03M

2.36%-4.18M

-2.24%-4.6M

-24.53%-5.78M

3.51%-4.48M

-22.10%-18.05M

15.13%-4.28M

-0.52%-4.49M

Depreciation and amortization

-95.87%6.57K

30.24%6.57K

2,538.67%177.4K

30.27%6.57K

291.61%6.58K

--159.2K

--5.04K

--6.72K

--5.04K

--1.68K

Other non cash items

----

-52.93%31.54K

168.48%14.26K

----

104.01%67K

---20.82K

--20.82K

Change In working capital

-114.22%-132.03K

144.53%722.62K

37.14%234.76K

-7.15%592.44K

129.66%336.46K

513.42%928.53K

-414.36%-1.62M

109.70%171.18K

-1.85%638.09K

-159.19%-1.13M

-Change in receivables

--0

-43.24%39.88K

--0

1,191.93%79.6K

-136.41%-15.08K

-139.63%-24.64K

163.79%70.26K

-124.26%-26.04K

-101.98%-7.29K

-Change in prepaid assets

-106.10%-53.44K

99.59%-2.32K

156.32%842.42K

78.32%280.45K

-14.42%250.05K

541,297.53%876.74K

-368.16%-564.82K

142.11%328.66K

119.56%157.28K

-70.40%292.19K

-Change in payables and accrued expense

-213.07%-76.63K

170.41%726.9K

-151.20%-642.89K

-37.50%313.95K

100.54%7.7K

-21.58%67.77K

-279.64%-1.03M

-117.63%-255.93K

-62.70%502.34K

-301.88%-1.42M

-Change in other current assets

13.48%29.7K

13.35%28.77K

179.64%106.42K

----

--26.17K

--25.38K

--38.06K

----

-Change in other current liabilities

-16.94%-31.66K

-16.95%-30.73K

-1,026.56%-111.07K

-202.51%-29.82K

---27.89K

---27.07K

---26.28K

---9.86K

--0

-Change in other working capital

----

100.00%-1

Cash from discontinued investing activities

Operating cash flow

-10.71%-5.05M

35.25%-3.87M

-4.23%-18.09M

3.20%-3.44M

25.43%-4.11M

-4.81%-4.57M

-51.80%-5.97M

-21.36%-17.35M

13.17%-3.56M

-172.44%-5.5M

Investing cash flow

Cash flow from continuing investing activities

-0.26%2.54M

43.28%-3.31M

172.83%11.66M

-142.63%-2.12M

181.53%17.06M

6,017.70%2.55M

-5.84M

-16.01M

4.96M

-20.93M

Net PPE purchase and sale

----

94.15%-14.24K

--0

----

---243.26K

--0

---200.17K

Net investment purchase and sale

-0.81%2.54M

43.28%-3.31M

174.04%11.67M

-142.63%-2.12M

182.32%17.06M

--2.56M

---5.84M

---15.76M

--4.96M

---20.73M

Cash from discontinued investing activities

Investing cash flow

-0.26%2.54M

43.28%-3.31M

172.83%11.66M

-142.63%-2.12M

181.53%17.06M

6,017.70%2.55M

---5.84M

---16.01M

--4.96M

---20.93M

Financing cash flow

Cash flow from continuing financing activities

9,115.33%3.24M

-95.72%367K

4,204.63%8.41M

-138.1K

-35.99K

4,289.61%8.58M

-100.50%-204.77K

Net issuance payments of debt

----

--0

----

-485.20%-248.91K

--0

Net common stock issuance

9,030.27%3.21M

-95.37%397.61K

--8.54M

--452

--70

---35.99K

--8.58M

--0

Proceeds from stock option exercised by employees

----

--0

----

-43.77%44.14K

--0

Net other financing activities

----

---30.61K

---138.56K

----

Cash from discontinued financing activities

Financing cash flow

9,115.33%3.24M

-95.72%367K

4,204.63%8.41M

---138.1K

--70

---35.99K

4,289.61%8.58M

-100.50%-204.77K

--0

Net cash flow

Beginning cash position

-40.52%2.35M

27.50%9.17M

-82.36%7.19M

157.03%14.86M

-94.09%1.91M

-89.19%3.96M

-82.36%7.19M

192.04%40.75M

-87.11%5.78M

-31.22%32.21M

Current changes in cash

135.74%733.11K

-110.77%-6.81M

105.89%1.98M

-504.95%-5.7M

149.02%12.96M

53.36%-2.05M

21.91%-3.23M

-225.25%-33.56M

134.34%1.41M

-1,227.75%-26.43M

End cash Position

62.01%3.09M

-40.52%2.35M

27.50%9.17M

157.03%14.86M

-94.09%1.91M

-89.19%3.96M

-82.36%7.19M

-87.11%5.78M

Free cash flow

-10.37%-5.05M

35.25%-3.87M

-2.87%-18.1M

3.20%-3.44M

28.04%-4.11M

-4.11%-4.58M

-51.80%-5.97M

-23.06%-17.59M

13.17%-3.56M

-182.35%-5.7M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-10.71%-5.05M	35.25%-3.87M	-4.23%-18.09M	3.20%-3.44M	25.43%-4.11M	-4.81%-4.57M	-51.80%-5.97M	-21.36%-17.35M	13.17%-3.56M	-172.44%-5.5M
Net income from continuing operations	14.16%-4.96M	-3.84%-4.65M	-5.40%-19.03M	2.36%-4.18M	-2.24%-4.6M	-24.53%-5.78M	3.51%-4.48M	-22.10%-18.05M	15.13%-4.28M	-0.52%-4.49M
Depreciation and amortization	-95.87%6.57K	30.24%6.57K	2,538.67%177.4K	30.27%6.57K	291.61%6.58K	--159.2K	--5.04K	--6.72K	--5.04K	--1.68K
Other non cash items	----	----	-52.93%31.54K	168.48%14.26K	----	----	----	104.01%67K	---20.82K	--20.82K
Change In working capital	-114.22%-132.03K	144.53%722.62K	37.14%234.76K	-7.15%592.44K	129.66%336.46K	513.42%928.53K	-414.36%-1.62M	109.70%171.18K	-1.85%638.09K	-159.19%-1.13M
-Change in receivables	--0	--0	-43.24%39.88K	--0	1,191.93%79.6K	-136.41%-15.08K	-139.63%-24.64K	163.79%70.26K	-124.26%-26.04K	-101.98%-7.29K
-Change in prepaid assets	-106.10%-53.44K	99.59%-2.32K	156.32%842.42K	78.32%280.45K	-14.42%250.05K	541,297.53%876.74K	-368.16%-564.82K	142.11%328.66K	119.56%157.28K	-70.40%292.19K
-Change in payables and accrued expense	-213.07%-76.63K	170.41%726.9K	-151.20%-642.89K	-37.50%313.95K	100.54%7.7K	-21.58%67.77K	-279.64%-1.03M	-117.63%-255.93K	-62.70%502.34K	-301.88%-1.42M
-Change in other current assets	13.48%29.7K	13.35%28.77K	179.64%106.42K	----	----	--26.17K	--25.38K	--38.06K	----	----
-Change in other current liabilities	-16.94%-31.66K	-16.95%-30.73K	-1,026.56%-111.07K	-202.51%-29.82K	---27.89K	---27.07K	---26.28K	---9.86K	---9.86K	--0
-Change in other working capital	----	----	----	----	----	----	----	----	----	100.00%-1
Cash from discontinued investing activities
Operating cash flow	-10.71%-5.05M	35.25%-3.87M	-4.23%-18.09M	3.20%-3.44M	25.43%-4.11M	-4.81%-4.57M	-51.80%-5.97M	-21.36%-17.35M	13.17%-3.56M	-172.44%-5.5M
Investing cash flow
Cash flow from continuing investing activities	-0.26%2.54M	43.28%-3.31M	172.83%11.66M	-142.63%-2.12M	181.53%17.06M	6,017.70%2.55M	-5.84M	-16.01M	4.96M	-20.93M
Net PPE purchase and sale	----	----	94.15%-14.24K	--0	--0	----	----	---243.26K	--0	---200.17K
Net investment purchase and sale	-0.81%2.54M	43.28%-3.31M	174.04%11.67M	-142.63%-2.12M	182.32%17.06M	--2.56M	---5.84M	---15.76M	--4.96M	---20.73M
Cash from discontinued investing activities
Investing cash flow	-0.26%2.54M	43.28%-3.31M	172.83%11.66M	-142.63%-2.12M	181.53%17.06M	6,017.70%2.55M	---5.84M	---16.01M	--4.96M	---20.93M
Financing cash flow
Cash flow from continuing financing activities	9,115.33%3.24M	-95.72%367K	4,204.63%8.41M	-138.1K	70	-35.99K	4,289.61%8.58M	-100.50%-204.77K	0	0
Net issuance payments of debt	----	----	--0	--0	----	----	----	-485.20%-248.91K	--0	--0
Net common stock issuance	9,030.27%3.21M	-95.37%397.61K	--8.54M	--452	--70	---35.99K	--8.58M	--0	--0	--0
Proceeds from stock option exercised by employees	----	----	--0	--0	----	----	----	-43.77%44.14K	--0	--0
Net other financing activities	----	---30.61K	---138.56K	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	9,115.33%3.24M	-95.72%367K	4,204.63%8.41M	---138.1K	--70	---35.99K	4,289.61%8.58M	-100.50%-204.77K	--0	--0
Net cash flow
Beginning cash position	-40.52%2.35M	27.50%9.17M	-82.36%7.19M	157.03%14.86M	-94.09%1.91M	-89.19%3.96M	-82.36%7.19M	192.04%40.75M	-87.11%5.78M	-31.22%32.21M
Current changes in cash	135.74%733.11K	-110.77%-6.81M	105.89%1.98M	-504.95%-5.7M	149.02%12.96M	53.36%-2.05M	21.91%-3.23M	-225.25%-33.56M	134.34%1.41M	-1,227.75%-26.43M
End cash Position	62.01%3.09M	-40.52%2.35M	27.50%9.17M	27.50%9.17M	157.03%14.86M	-94.09%1.91M	-89.19%3.96M	-82.36%7.19M	-82.36%7.19M	-87.11%5.78M
Free cash flow	-10.37%-5.05M	35.25%-3.87M	-2.87%-18.1M	3.20%-3.44M	28.04%-4.11M	-4.11%-4.58M	-51.80%-5.97M	-23.06%-17.59M	13.17%-3.56M	-182.35%-5.7M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data